The clinical and cost burden of coronary calcification in a Medicare cohort: An economic model to address under-reporting and misclassification

Cardiovasc Revasc Med. 2015 Oct-Nov;16(7):406-12. doi: 10.1016/j.carrev.2015.08.002. Epub 2015 Aug 12.

Abstract

Background: Coronary artery calcification (CAC) is a well-established risk factor for the occurrence of adverse ischemic events. However, the economic impact of the presence of CAC is unknown.

Objectives: Through an economic model analysis, we sought to estimate the incremental impact of CAC on medical care costs and patient mortality for de novo percutaneous coronary intervention (PCI) patients in the 2012 cohort of the Medicare elderly (≥65) population.

Methods: This aggregate burden-of-illness study is incidence-based, focusing on cost and survival outcomes for an annual Medicare cohort based on the recently introduced ICD9 code for CAC. The cost analysis uses a one-year horizon, and the survival analysis considers lost life years and their economic value.

Results: For calendar year 2012, an estimated 200,945 index (de novo) PCI procedures were performed in this cohort. An estimated 16,000 Medicare beneficiaries (7.9%) were projected to have had severe CAC, generating an additional cost in the first year following their PCI of $3500, on average, or $56 million in total. In terms of mortality, the model projects that an additional 397 deaths would be attributable to severe CAC in 2012, resulting in 3770 lost life years, representing an estimated loss of about $377 million, when valuing lost life years at $100,000 each.

Conclusions: These model-based CAC estimates, considering both moderate and severe CAC patients, suggest an annual burden of illness approaching $1.3 billion in this PCI cohort. The potential clinical and cost consequences of CAC warrant additional clinical and economic attention not only on PCI strategies for particular patients but also on reporting and coding to achieve better evidence-based decision-making.

Keywords: Calcification; Coronary; Economics; Medicare.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Coronary Artery Disease / classification
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / economics*
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / therapy*
  • Diagnostic Errors / economics
  • Female
  • Health Care Costs*
  • Humans
  • Incidence
  • International Classification of Diseases / economics*
  • Male
  • Medicare / economics*
  • Models, Economic*
  • Patient Selection
  • Percutaneous Coronary Intervention / adverse effects
  • Percutaneous Coronary Intervention / economics*
  • Percutaneous Coronary Intervention / mortality
  • Predictive Value of Tests
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • United States / epidemiology
  • Vascular Calcification / classification
  • Vascular Calcification / diagnosis
  • Vascular Calcification / economics*
  • Vascular Calcification / mortality
  • Vascular Calcification / therapy*